LinkedIn Facebook

Innovation

TimoD

A non-biodegradable intra-ocular implant delivering timolol maleate to treat glaucoma for minimum 3 years

Know more
ComboD

A non-biodegradable intra-ocular implant delivering two drugs to treat glaucoma for minimum 2 years

Know more
InflammaD

A biodegradable short-term implant, based on well-known drugs, to prevent inflammation and pain after eye surgery

TimoD

timod_post timod_post timod_post

A non-biodegradable intra-ocular implant delivering timolol to treat glaucoma for
minimum 2 years.

Read more...

Development Stage

timod_post timod_post

ComboD

ComboD ComboD ComboD

A non-biodegradable intra-ocular implant delivering precise controlled dose of two Active Pharmaceuticals Ingredients (APIs) in the eye.

Read more...

Development Stage

combod_post combod_post

InflammaD

InflammaD InflammaD InflammaD

A biodegradable short-term implant, based on well-known drugs, to prevent inflammation and pain after eye surgery.

Development Stage

inflammad_post inflammad_post

Our team

our-team_post our-team_post our-team_post

Our team aims to leverage on EyeD Pharma’s proprietary technological platform to enhance our product portfolio in line with our corporate strategy, either on a standalone basis or through dedicated partnerships, from the idea to the market.

Our teams are indeed able, on the basis of clinical unmet needs identified by clinicians or industrial partners, to provide a full development approach for an implant releasing drug product candidate including formulation, non-clinical and clinical project management, Regulatory Affairs, Market Access Strategy, Manufacturing and industrialization, thanks to Unid Manufacturing, our fully owned CDMO located near Liège, Belgium.

Highlights

PInnovation_GraphicTeam_01.svg Average age
of innovation team
Innovation_GraphicTeam_02.svg Innovation Staff
by Departments

Our news

Sorry, nothing to show for the moment...

Our values

Patient Driven

All our product candidates aim to enhance patient quality of life and are based on clinical unmet need identified by internationally renowned KOL’s

Patient Driven
Breakthrough Innovation

We manage all the expertise and processes, from the idea to the market

Breakthrough Innovation
Corporate Responsibility

Creation of high-quality long-term employment and significant contribution to the economic redeployment of Wallonia. Eyed’s team is today composed of 66 FTEs

Corporate Responsibility
Humanitarian Mission

Our technological platform allows to give access to long term innovative ophthalmological treatments to developing countries populations, where glaucoma is the second cause of blindness

Humanitarian Mission